Results
1 -
4 of
4Hengmiao Cheng, Shubha Bagrodia, Simon Bailey, Martin Edwards, Jacqui Hoffman, Qiyue Hu, Robert Kania, Daniel R. Knighton, Matthew A. Marx, Sacha Ninkovic, Shaoxian Sun and Eric Zhang.
Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design, Med. Chem. Commun., 2010, 1, 139. Lin Songwen, Han Fangbin, Liu Peng, Tao Jing, Zhong Xuechao, Liu Xiujie, Yi Chongqin, Xu Heng.
Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors, Bioorganic & Medicinal Chemistry Letters, 2014 Ma Xiao-Dong, Qiu Ni, Yang Bo, He Qiao-Jun, Hu Yong-Zhou.
Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation, Med. Chem. Commun., 2016 R.-L. Du, N. Sun, Y.-H. Fung, Y.-Y. Zheng, Y.-W. Chen, P.-H. Chan, et al..
1